Parallax Volatility Advisers, L.P. Blueprint Medicines Corp Put Options Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $949,500 - $1.49 Million	22,500 New	22,500 $1.42 Million
Q1 2019 May 15, 2019	SELL	$48.7 - $86.6 $175,320 - $311,760	-3,600 Reduced 26.47%	10,000 $801,000
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $829,056 - $1.38 Million	13,600 New	13,600 $863,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.47B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.